Inflammation Model Articles & Analysis
4 news found
We are proud to introduce Myelotracker®, a peptide-based probe. This unique technology specifically targets lactoferrin, a major protein stored in neutrophil granules, making it possible to visualize and study these immune cells with unmatched precision. Unlike many existing tools, Myelotracker does not activate neutrophils, preserving their natural physiological state and ensuring reliable ...
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the ...
Title: "LEUCONOSTOC SP. LB-P8 AMELIORATES LIVER INFLAMMATION AND FIBROSIS IN DIET-INDUCED NON-ALCOHOLIC STEATOHEPATITIS" Oral Presentation Date and Time: Monday, November 7, 2022, 4:30 PM AASLD is the leading global association in the liver disease field founded in 1950. ...
ILB® represents an exciting new therapy that not only controls inflammation to prevent the development of fibrotic scarring, but also activates tissue remodelling processes so that established scar tissue is dissolved. ...